| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10004783 | HBV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
| TVIS30074531 | HIV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
| TVIS30022908 | HIV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | OPRD1 |
|---|---|
| DrugBank ID | DB00497 |
| Drug Name | Oxycodone |
| Target ID | BE0000420 |
| UniProt ID | P41143 |
| Regulation Type | agonist |
| PubMed IDs | 17525040; 11752352 |
| Citations | Ordonez Gallego A, Gonzalez Baron M, Espinosa Arranz E: Oxycodone: a pharmacological and clinical review. Clin Transl Oncol. 2007 May;9(5):298-307.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Illicit; Investigational |
| Direct Classification | Phenanthrenes and derivatives |
| SMILES | COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C |
| Pathways | Oxycodone Action Pathway |
| PharmGKB | PA450741 |
| ChEMBL | CHEMBL656 |
